Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recent advances in the genomics and therapy of BCR/ABL1-positive and -negative chronic myeloproliferative neoplasms.
Mughal TI, Gotlib J, Mesa R, Koschmieder S, Khoury HJ, Cortes JE, Barbui T, Hehlmann R, Mauro M, Saussele S, Radich JP, Van Etten RA, Saglio G, Verstovek S, Gale RP, Abdel-Wahab O. Mughal TI, et al. Among authors: gale rp. Leuk Res. 2018 Apr;67:67-74. doi: 10.1016/j.leukres.2018.02.008. Epub 2018 Feb 14. Leuk Res. 2018. PMID: 29466766 Free PMC article. Review.
BCR/ABL and leukemia.
Butturini A, Arlinghaus RB, Gale RP. Butturini A, et al. Among authors: gale rp. Leuk Res. 1996 Jun;20(6):523-9. doi: 10.1016/0145-2126(95)00057-7. Leuk Res. 1996. PMID: 8709625 Review.
Immune therapy of chronic myelogenous leukemia.
Gale RP, Horowitz MM, Talpaz M, Scheinberg DA, Molldrem J, Li Z, Baccarani M, Goldman JM, Tura S. Gale RP, et al. Leuk Res. 2005 May;29(5):583-6. doi: 10.1016/j.leukres.2004.11.005. Leuk Res. 2005. PMID: 15755511 No abstract available.
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
Lee SJ, Kukreja M, Wang T, Giralt SA, Szer J, Arora M, Woolfrey AE, Cervantes F, Champlin RE, Gale RP, Halter J, Keating A, Marks DI, McCarthy PL, Olavarria E, Stadtmauer EA, Abecasis M, Gupta V, Khoury HJ, George B, Hale GA, Liesveld JL, Rizzieri DA, Antin JH, Bolwell BJ, Carabasi MH, Copelan E, Ilhan O, Litzow MR, Schouten HC, Zander AR, Horowitz MM, Maziarz RT. Lee SJ, et al. Among authors: gale rp. Blood. 2008 Oct 15;112(8):3500-7. doi: 10.1182/blood-2008-02-141689. Epub 2008 Jul 29. Blood. 2008. PMID: 18664621 Free PMC article.
MPN-associated myelofibrosis (MPN-MF).
Mesa RA, Green A, Barosi G, Verstovsek S, Vardiman J, Gale RP. Mesa RA, et al. Among authors: gale rp. Leuk Res. 2011 Jan;35(1):12-3. doi: 10.1016/j.leukres.2010.07.019. Epub 2010 Aug 4. Leuk Res. 2011. PMID: 20684988 No abstract available.
What are RBC-transfusion-dependence and -independence?
Gale RP, Barosi G, Barbui T, Cervantes F, Dohner K, Dupriez B, Gupta V, Harrison C, Hoffman R, Kiladjian JJ, Mesa R, Mc Mullin MF, Passamonti F, Ribrag V, Roboz G, Saglio G, Vannucchi A, Verstovsek S. Gale RP, et al. Leuk Res. 2011 Jan;35(1):8-11. doi: 10.1016/j.leukres.2010.07.015. Epub 2010 Aug 7. Leuk Res. 2011. PMID: 20692036 Free PMC article.
Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis.
Khoury HJ, Kukreja M, Goldman JM, Wang T, Halter J, Arora M, Gupta V, Rizzieri DA, George B, Keating A, Gale RP, Marks DI, McCarthy PL, Woolfrey A, Szer J, Giralt SA, Maziarz RT, Cortes J, Horowitz MM, Lee SJ. Khoury HJ, et al. Among authors: gale rp. Bone Marrow Transplant. 2012 Jun;47(6):810-6. doi: 10.1038/bmt.2011.194. Epub 2011 Oct 10. Bone Marrow Transplant. 2012. PMID: 21986636 Free PMC article. Clinical Trial.
RBC-transfusion guidelines update.
Gale RP, Barosi G, Barbui T, Cervantes F, Dohner K, Dupriez B, Gupta V, Harrison C, Hoffman R, Kiladjian JJ, Mesa R, Mc Mullin MF, Passamonti F, Ribrag V, Roboz G, Saglio G, Vannucchi A, Verstovsek S. Gale RP, et al. Leuk Res. 2012 May;36(5):659-60. doi: 10.1016/j.leukres.2012.01.023. Epub 2012 Feb 14. Leuk Res. 2012. PMID: 22336392 Free PMC article. No abstract available.
1,143 results